ABSTRACT GALE, GLEN R. (Veterans Administration Hospital, Durham, N.C.). Urease activity and antibiotic sensitivity of bacteria. J. Bacteriol. 91:499-506. 1966.-An investigation was made of the responses of certain urease-positive bacteria to various antibacterial drugs in the presence of highly specific urease inhibitors, in a test of the hypothesis proposed by other workers that inhibition of bacterial urease enhances the sensitivity of the cells to antimicrobial agents. Urease inhibitors employed were seven hydroxamic acids (HA). Six of the seven HA reduced the sensitivity of nine Proteus strains to ampicillin and methenamine mandelate. Two HA increased the sensitivity to colistin, and six HA increased the sensitivity to kanamycin. Investigation of the mechanism of action of the synergistic effect between kanamycin and HA led to the tentative conclusion that potentiation was mediated through an initial alteration of cell permeability by the aminoglycoside antibiotic which permitted accumulation of each of the six HA into the cell, at which point each interacted with pyridoxal phosphate. The single HA which failed to yield synergism with kanamycin failed to interact with pyridoxal phosphate in a nonenzymatic system; the other six HA produced alterations of the normal ultraviolet absorption spectrum of the coenzyme.
Extensive investigations by Seneca (7) and co-workers have yielded implications of a close association of antibiotic resistance with certain enzymes, particularly urease, in bacteria. Conclusions were based on the finding that drugresistant bacteria can be made drug-susceptible, in many cases, through the action of enzyme inhibitors. In tests of organic mercurial compounds in vitro, inhibition of bacterial growth was shown to occur concomitantly with inhibition of urease.
Kobashi, Hase, and Uehara (6) have demonstrated that a number of hydroxamic acids (HA) are potent, highly specific inhibitors of urease, combining with it at its active site. The prototype of this group of compounds, acetyl hydroxamic acid, has no inhibitory action on a variety of other enzymes: ,s-amylase, papain, protease, ,6-glycerophosphatase, alcohol dehydrogenase, lactic dehydrogenase, vitamin K3 reductase, catalase, and pyruvic carboxylase. Unlike the organic mercurial compounds used by Seneca (7) , many HA are devoid of significant antimicrobial activity (unpublished data), and those which do possess such action are of limited spectra (4a, 5) .
In view of the availability of this group of compounds with urease inhibitory activity but with only limited antibacterial activity, a study was made of the effects of some of these agents on the responses of certain urease-positive organisms to a number of antibacterial drugs. MATERIALS was rather large in each experiment. As an example, 4 mg/ml of kanamycin alone inhibited strain 622 an average of about i1 % in six experiments (Table 2 ). This was increased to up to 80% with 500 ,ug/ml of LAHA. No experiment failed to show a clear enhancement of inhibition. Data on HU are not included in Tables 2 to 4 , because values obtained with up to 500 lAg/ml of HU in the presence of kanamycin did not differ appreciably from values obtained with kanamycin alone.
These data, although not completely in accord with the suggestions of Seneca (7) regarding a direct relationship between urease activity and drug susceptibility, unequivocably demonstrate significant potentiation in vitro of inhibition of Proteus by kanamycin in the presence of certain urease inhibitors. Consistent inability to demonstrate such an enhancement with kanamycin plus HU, however, casts some doubt that the potentiation is due to the urease inhibitory activity per se of the HA, since HU was shown to be inhibitory to the cell-free urease preparation as well as to the enzyme in intact cells. Regarding the mechanism of potentiation, it appeared of interest to inspect other properties of the HA in an effort to determine whether HU differs in some way from the other six HA.
In a previous report (Gale, Can. J. Microbiol., in press), it was shown that two HA with antimycobacterial properties were antagonized by pyridoxal phosphate (PyP), and formed complexes with PyP as evidenced by alterations in the ultraviolet absorption spectrum of the coenzyme. To determine whether the synergism herein described is antagonized by PyP, culture flasks were prepared containing graded concen- trations of kanamycin, with and without LAHA and LAHA plus PyP. Figure 3 shows reversal of the synergism by PyP.
As a consequence of this observation, the effect of each HA on the ultraviolet absorption spectrum of PyP was determined after mixing aqueous solutions of each acid. In addition, two hydroxamates of carboxylic nonamino acids, propionyl HA (PHA) and butyryl HA (BHA), were included in the scans, as well as hydroxyla- Figure 4 (A Fig. 4D . Fitzgerald and Bemheim (3) described an antagonism by urea of the bacteriostatic action of streptomycin on a mycobacterium and on Escherichia coli. Since streptomycin and kanamycin are closely related structurally and have a similar action on peptide synthesis at the ribosomal level (1), it was considered of interest to determine whether exogenous urea in any way influences the action of kanamycin on Proteus. With the use of three strains of the organism and procedures substantially the same as those used to obtain the data in Tables 2 to 4 , it was found that the presence of urea at concentrations up to 2,000 ,ug/ml in no way altered the response of the cells to kanamycin. Therefore, no reciprocal relationship exists between synergism of kanamycin by urease inhibitors on the one hand, and antagonism of kanamycin by stimulating the enzyme to possibly greater velocity through added substrate. Besides this apparent difference in streptomycin and kanamycin, preliminary experiments with the three Proteus strains showed that the action of streptomycin was in no way influenced by the presence of urease inhibitors.
Experiments designed to demonstrate the antagonism by urease inhibitors of the action of ampicillin and methenamine mandelate confirmed the results of the plate tests and showed a considerable reversal of the action of ampicillin by LAHA (Fig. 5) . The mechanism of this antagonism has not been investigated. Experiments with methenamine mandelate and LAHA similarly revealed that antagonism of the former by the latter was not due simply to an effect on rate of diffusion of methenamine mandelate in the plate tests. However, the three strains tested were not markedly susceptible to methenamine mandelate in liquid shake culture, even after adjusting the pH of the medium to 6.5. A typical experiment showed that 600 ,g/ml conferred 20% inhibition, and this value was reduced to 5% in the presence of 200 ,g/ml of LAHA.
Tests employing seven strains of Pseudomonas showed that none of the six HA which were synergistic with kanamycin altered in any way the responses of the organisms to the eight antimicrobial drugs. The seventh, HU, is inhibitory to Pseudomonas (5).
DiscussIoN
The foregoing data indicate that, within the limits of the seven HA and eight antibacterial drugs tested against nine strains of Proteus, no definite and consistent correlation exists between inhibition of bacterial urease per se and enhanced sensitivity to antimicrobial agents, as has been proposed by Seneca (7) . Indeed, investigations regarding the mechanism of action of kanamycin (1, 2) at its presumably principal site of action at the ribosomal level have not implicated urea or urease as being a contributory factor.
In view of the fact that the six HA which enhance the action of kanamycin are the same compounds which interact with PyP in a nonenzymatic system, and the potentiated antimicrobial activity is antagonized by PyP, the actual mechanism of antibacterial action would appear to be mediated by HA rather than by kanamycin. The known property of aminoglycoside antibiotics of inducing marked changes in cell permeability, thereby promoting a possibly greater accumulation of the six HA in the cell, is not incompatible with such a hypothesis.
Experiments have been initiated to determine whether certain HA which possess antimycobacterial properties (4a) show an increased activity against mycobacteria when combined with kanamycin.
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